View in EDS HTML Full Text PDF Full Text

Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy.

Saved in:
Bibliographic Details
Title: Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy.
Authors: Lutz R; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; Oncology Center Speyer, Speyer, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany., Grünschläger F; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Simon M; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany., Awwad MHS; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Bauer M; Institute of Pathology, University Hospital Halle, Martin Luther University Halle-, Wittenberg, Germany., Yousefian S; Berlin Institute of Health (BIH) at Charité Universitätsmedizin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Charité Universitätsmedizin, Berlin, Germany., Beumer N; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany., Jopp-Saile L; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Sedlmeier A; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany., Solé-Boldo L; Berlin Institute of Health (BIH) at Charité Universitätsmedizin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Charité Universitätsmedizin, Berlin, Germany., Avanesyan B; Berlin Institute of Health (BIH) at Charité Universitätsmedizin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Charité Universitätsmedizin, Berlin, Germany., Vonficht D; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Stelmach P; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany., Steinbuss G; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Boch T; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany., Steiger S; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany., Baertsch MA; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Prokoph N; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Rippe K; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany., Durie BGM; Cedars-Sinai Medical Center, Los Angeles, CA, USA., Wickenhauser C; Institute of Pathology, University Hospital Halle, Martin Luther University Halle-, Wittenberg, Germany., Trumpp A; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany., Müller-Tidow C; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; Molecular Medicine Partnership Unit EMBL and University Hospital Heidelberg, Heidelberg, Germany., Hübschmann D; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Innovation and Service Unit for Bioinformatics and Precision Medicine (BPM), German Cancer Research Center (DKFZ), Heidelberg, Germany., Weinhold N; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Raab MS; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Brors B; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany. b.brors@dkfz-heidelberg.de.; Medical Faculty and Faculty of Biosciences, Heidelberg University, Heidelberg, Germany. b.brors@dkfz-heidelberg.de.; National Center for Tumor Diseases (NCT), Heidelberg, Germany. b.brors@dkfz-heidelberg.de.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany. b.brors@dkfz-heidelberg.de., Goldschmidt H; Department of Medicine V, Hematology, Oncology and Rheumatology, GMMG Studygroup, Heidelberg University Hospital, Heidelberg, Germany. hartmut.goldschmidt@med.uni-heidelberg.de., Imbusch CD; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany. c.imbusch@dkfz-heidelberg.de.; Institute of Immunology, University Medical Center Mainz, Mainz, Germany. c.imbusch@dkfz-heidelberg.de.; Research Center for Immunotherapy, University Medical Center Mainz, Mainz, Germany. c.imbusch@dkfz-heidelberg.de.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Mainz, Germany. c.imbusch@dkfz-heidelberg.de., Hundemer M; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany. michael.hundemer@med.uni-heidelberg.de., Haas S; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany. simon.haas@bih-charite.de.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany. simon.haas@bih-charite.de.; Berlin Institute of Health (BIH) at Charité Universitätsmedizin, Berlin, Germany. simon.haas@bih-charite.de.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. simon.haas@bih-charite.de.; Charité Universitätsmedizin, Berlin, Germany. simon.haas@bih-charite.de.; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK. simon.haas@bih-charite.de.
Source: Nature communications [Nat Commun] 2024 Nov 29; Vol. 15 (1), pp. 10396. Date of Electronic Publication: 2024 Nov 29.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39613747
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lutz+R%22">Lutz R</searchLink>; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; Oncology Center Speyer, Speyer, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Grünschläger+F%22">Grünschläger F</searchLink>; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Simon+M%22">Simon M</searchLink>; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Awwad+MHS%22">Awwad MHS</searchLink>; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Bauer+M%22">Bauer M</searchLink>; Institute of Pathology, University Hospital Halle, Martin Luther University Halle-, Wittenberg, Germany.<br /><searchLink fieldCode="AU" term="%22Yousefian+S%22">Yousefian S</searchLink>; Berlin Institute of Health (BIH) at Charité Universitätsmedizin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Charité Universitätsmedizin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Beumer+N%22">Beumer N</searchLink>; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Jopp-Saile+L%22">Jopp-Saile L</searchLink>; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Sedlmeier+A%22">Sedlmeier A</searchLink>; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Solé-Boldo+L%22">Solé-Boldo L</searchLink>; Berlin Institute of Health (BIH) at Charité Universitätsmedizin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Charité Universitätsmedizin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Avanesyan+B%22">Avanesyan B</searchLink>; Berlin Institute of Health (BIH) at Charité Universitätsmedizin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Charité Universitätsmedizin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Vonficht+D%22">Vonficht D</searchLink>; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Stelmach+P%22">Stelmach P</searchLink>; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Steinbuss+G%22">Steinbuss G</searchLink>; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Boch+T%22">Boch T</searchLink>; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Steiger+S%22">Steiger S</searchLink>; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Baertsch+MA%22">Baertsch MA</searchLink>; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Prokoph+N%22">Prokoph N</searchLink>; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Rippe+K%22">Rippe K</searchLink>; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Durie+BGM%22">Durie BGM</searchLink>; Cedars-Sinai Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wickenhauser+C%22">Wickenhauser C</searchLink>; Institute of Pathology, University Hospital Halle, Martin Luther University Halle-, Wittenberg, Germany.<br /><searchLink fieldCode="AU" term="%22Trumpp+A%22">Trumpp A</searchLink>; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Müller-Tidow+C%22">Müller-Tidow C</searchLink>; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; Molecular Medicine Partnership Unit EMBL and University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hübschmann+D%22">Hübschmann D</searchLink>; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Innovation and Service Unit for Bioinformatics and Precision Medicine (BPM), German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Weinhold+N%22">Weinhold N</searchLink>; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Raab+MS%22">Raab MS</searchLink>; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Brors+B%22">Brors B</searchLink>; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany. b.brors@dkfz-heidelberg.de.; Medical Faculty and Faculty of Biosciences, Heidelberg University, Heidelberg, Germany. b.brors@dkfz-heidelberg.de.; National Center for Tumor Diseases (NCT), Heidelberg, Germany. b.brors@dkfz-heidelberg.de.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany. b.brors@dkfz-heidelberg.de.<br /><searchLink fieldCode="AU" term="%22Goldschmidt+H%22">Goldschmidt H</searchLink>; Department of Medicine V, Hematology, Oncology and Rheumatology, GMMG Studygroup, Heidelberg University Hospital, Heidelberg, Germany. hartmut.goldschmidt@med.uni-heidelberg.de.<br /><searchLink fieldCode="AU" term="%22Imbusch+CD%22">Imbusch CD</searchLink>; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany. c.imbusch@dkfz-heidelberg.de.; Institute of Immunology, University Medical Center Mainz, Mainz, Germany. c.imbusch@dkfz-heidelberg.de.; Research Center for Immunotherapy, University Medical Center Mainz, Mainz, Germany. c.imbusch@dkfz-heidelberg.de.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Mainz, Germany. c.imbusch@dkfz-heidelberg.de.<br /><searchLink fieldCode="AU" term="%22Hundemer+M%22">Hundemer M</searchLink>; Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany. michael.hundemer@med.uni-heidelberg.de.<br /><searchLink fieldCode="AU" term="%22Haas+S%22">Haas S</searchLink>; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany. simon.haas@bih-charite.de.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany. simon.haas@bih-charite.de.; Berlin Institute of Health (BIH) at Charité Universitätsmedizin, Berlin, Germany. simon.haas@bih-charite.de.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. simon.haas@bih-charite.de.; Charité Universitätsmedizin, Berlin, Germany. simon.haas@bih-charite.de.; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK. simon.haas@bih-charite.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Nov 29; Vol. 15 (1), pp. 10396. <i>Date of Electronic Publication: </i>2024 Nov 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39613747
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-024-54543-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 10396
    Titles:
      – TitleFull: Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lutz R
      – PersonEntity:
          Name:
            NameFull: Grünschläger F
      – PersonEntity:
          Name:
            NameFull: Simon M
      – PersonEntity:
          Name:
            NameFull: Awwad MHS
      – PersonEntity:
          Name:
            NameFull: Bauer M
      – PersonEntity:
          Name:
            NameFull: Yousefian S
      – PersonEntity:
          Name:
            NameFull: Beumer N
      – PersonEntity:
          Name:
            NameFull: Jopp-Saile L
      – PersonEntity:
          Name:
            NameFull: Sedlmeier A
      – PersonEntity:
          Name:
            NameFull: Solé-Boldo L
      – PersonEntity:
          Name:
            NameFull: Avanesyan B
      – PersonEntity:
          Name:
            NameFull: Vonficht D
      – PersonEntity:
          Name:
            NameFull: Stelmach P
      – PersonEntity:
          Name:
            NameFull: Steinbuss G
      – PersonEntity:
          Name:
            NameFull: Boch T
      – PersonEntity:
          Name:
            NameFull: Steiger S
      – PersonEntity:
          Name:
            NameFull: Baertsch MA
      – PersonEntity:
          Name:
            NameFull: Prokoph N
      – PersonEntity:
          Name:
            NameFull: Rippe K
      – PersonEntity:
          Name:
            NameFull: Durie BGM
      – PersonEntity:
          Name:
            NameFull: Wickenhauser C
      – PersonEntity:
          Name:
            NameFull: Trumpp A
      – PersonEntity:
          Name:
            NameFull: Müller-Tidow C
      – PersonEntity:
          Name:
            NameFull: Hübschmann D
      – PersonEntity:
          Name:
            NameFull: Weinhold N
      – PersonEntity:
          Name:
            NameFull: Raab MS
      – PersonEntity:
          Name:
            NameFull: Brors B
      – PersonEntity:
          Name:
            NameFull: Goldschmidt H
      – PersonEntity:
          Name:
            NameFull: Imbusch CD
      – PersonEntity:
          Name:
            NameFull: Hundemer M
      – PersonEntity:
          Name:
            NameFull: Haas S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 11
              Text: 2024 Nov 29
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1